Evidence map›Paper›PMID 32102525›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

Assessment of Serum CoQ10 Levels and other Antioxidant Markers in Breast Cancer.

Eman El-Attar, Amel Kamel, Ahmed Karmouty, Nadine Wehida, Rasha Nassra, Mohamed El Nemr, Noha Said Kandil

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. The Role of miRNA-182 and FOXO3 Expression in Breast Cancer.Asian Pacific journal of cancer prevention : APJCP · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Eman El-AttarDepartment of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Amel KamelDepartment of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Ahmed KarmoutyDepartment of Experimental and Clinical Surgery, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Nadine WehidaDepartment of Pharmacology and Therapeutics, Pharos University in Alexandria, Alexandria, Egypt.
Rasha NassraDepartment of Medical Biochemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Mohamed El NemrDepartment of Cancer Management and Research, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Noha Said KandilDepartment of Chemical Pathology, Medical Research Institute, Alexandria University, Alexandria, Egypt.
Alexandria University · EGPharos University in Alexandria · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe balance of the oxidative state in the body is fundamental for the maintenance of homeostasis. It has been implicated in the onset and progression of several diseases including breast cancer. The way in which the Reactive Oxygen Species (ROS) / antioxidants balance leads to or responds to disease is still controversial. In this study, TAC is used as a reference for the total antioxidant power of the body and Coenzyme Q10 (CoQ10) for its vital importance in cellular antioxidant action and being the only lipid soluble antioxidant synthesized endogenously. Copper and zinc were measured as trace elements reflecting the antioxidant micronutrient profile of the body.

methodsAfter approval of the ethical committee, 60 recently diagnosed non-intervened breast cancer patients were recruited from the Medical Research Institute hospital, Alexandria University along with 20 apparently healthy volunteers as control group. Full patient history was taken including breastfeeding history, parity, hormone replacement therapy use, body mass index, pathological examination, metastatic work up results, past medical history and drug use. CA 15-3 and laboratory investigations evaluating blood glucose, kidney and liver functions were performed. Q10 levels were measured by HPLC using a kit from Recipe®. TAC was assayed spectrophotometrically (Biodiagnostics®). Copper and Zinc levels were determined by inductively coupled plasma-optical emission spectrometry.

resultsThere was a statistically significant increase in the CoQ10, TAC and copper levels in the breast cancer group when compared to the control group. Zinc showed no statistically significant difference between the studied groups.

conclusionInspite of the fact that a high antioxidant level is usually considered as a favourable state, TAC, CoQ10 and copper levels showed significantly higher levels in the breast cancer group when compared to the control group. It is worth mentioning that the cancer group were all recently diagnosed, non-intervened and showed no signs of metastasis. It is still unclear whether the increased antioxidant levels offer a selective growth advantage to tumor cells over their surrounding normal cells or serve as a protective measure by the body in an attempt to correct the assault triggered by the ROS.

Indexed as

AdultAntioxidantsBiomarkersBreast NeoplasmsCase-Control StudiesCopperFemaleHumansMiddle AgedReactive Oxygen SpeciesUbiquinoneZincAntioxidantsBiomarkerscoenzyme Q10CopperReactive Oxygen SpeciesUbiquinoneZincbreast cancerCoQ10serum copper, serum zincTotal Antioxidant Capacity

Identifiers

PMID32102525
PMCPMC7332135
OpenAlexW3007976723

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.